Press release
Global Cardiac Biomarkers Testing Devices Market to Exhibit Growth at a Considerable CAGR of 7.77% by 2028, Estimates DelveInsight | Beckman Coulter, Siemens, Abbott, bioMérieux, Roche, Thermo Fischer Scientific Inc, Bio-Rad, Eurolyser, DIALAB GmbH
DelveInsight's "Cardiac Biomarkers Testing Devices Market" research report provides the current and forecasted Cardiac Biomarkers Testing Devices market size, share, and trends analysis for the next five years, upcoming innovations in the segment, and major market drivers & barriers. The report also covers the key competitors and emerging devices in the domain.
Cardiac Biomarkers Testing Devices: Overview
Cardiac biomarkers testing devices are medical devices designed to measure specific proteins or substances released into the bloodstream in response to heart-related conditions or events. These biomarkers serve as indicators of cardiac injury, stress, or dysfunction, and their measurement helps healthcare professionals diagnose, monitor, and manage various cardiac conditions. Cardiac biomarkers testing devices play a critical role in the early detection and risk stratification of cardiovascular diseases. Commonly measured cardiac biomarkers include Troponin, Creatine Kinase (CK)/CK-MB, Myoglobin, and BNP/NT-proBNP.
Cardiac biomarkers testing devices are used for various purposes in the field of cardiology. Some of the major uses of Cardiac Biomarkers Testing Devices include:
• Diagnosing Acute Myocardial Infarction (Heart Attack): The measurement of troponin and CK-MB levels helps in the early diagnosis of a heart attack, allowing prompt initiation of appropriate treatment.
• Risk Stratification: Cardiac biomarker testing aids in assessing the severity and prognosis of cardiovascular events. Elevated biomarker levels may indicate a higher risk of adverse outcomes.
• Monitoring Heart Failure: BNP and NT-proBNP testing are valuable tools for monitoring patients with heart failure, helping healthcare professionals adjust treatment plans and assess response to therapies.
• Assessment of Chest Pain: Cardiac biomarkers testing can help distinguish between various causes of chest pain, such as heart-related issues, versus non-cardiac conditions.
• Monitoring Cardiac Procedures: Cardiac biomarker testing is used before and after cardiac procedures (e.g., angioplasty, coronary artery bypass grafting) to evaluate any procedure-related cardiac injury.
• Assessing Cardiac Health in the Emergency Department: Cardiac biomarker testing is often performed in emergency departments to quickly rule out or confirm a heart attack in patients presenting with chest pain or other cardiac symptoms.
Cardiac biomarkers testing devices can range from simple point-of-care devices to more advanced laboratory-based analyzers. Rapid and accurate testing using these devices is essential for timely and appropriate patient management in various cardiac scenarios. Interpretation of biomarker results is typically done in conjunction with clinical history, electrocardiography (ECG), imaging studies, and other diagnostic assessments to form a comprehensive evaluation of a patient's cardiac health.
Cardiac Biomarkers Testing Devices Market - Key Takeaways
• Some of the key factors such as the rising prevalence of cardiovascular diseases, growing aging population, advancements in technology, preference for point-of-care testing, favorable government initiatives, and healthcare policies, among others, are anticipated to drive the Cardiac Biomarkers Testing Devices Market.
• Challenges in sample collection and result delivery, a limited understanding of the biochemistry of the biomarkers, and a lack of sensitivity and specificity to cardiac muscle necrosis could limit the growth of the cardiac biomarker testing market.
• In the biomarker type segment of the cardiac biomarker testing devices market, the troponin category of cardiac biomarkers is predicted to account for the largest market revenue share. This can be ascribed to the fact that it is considered the best cardiac biomarker among all other cardiac biomarker types. This protein is by far the most commonly used biomarker and has the highest known sensitivity.
• North America is anticipated to hold the greatest market share for cardiac biomarker testing among all the regions. Over the course of the forecast period, it is expected that the rising prevalence of cardiovascular diseases, improved healthcare facilities, the presence of major market players, and higher investment in research and development activities in the region will have a significant impact on the market for cardiac biomarker testing.
Get a more Detailed Overview of the Major Trends and Key Dynamics Shaping the Market Outlook @
https://www.delveinsight.com/report-store/cardiac-biomarkers-testing-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Cardiac Biomarkers Testing Devices Market - Key Developments and Breakthroughs
Over the years, the Cardiac Biomarkers Testing Devices market has evolved significantly owing to the active participation of global companies and technological advancements in the domain. Some of the major advancements in recent years in the Cardiac Biomarkers Testing Devices market are -
• In April 2021, Roche announced the series of five new intended uses for two key cardiac biomarkers using the Elecsys® technology: high sensitive cardiac troponin T (cTnT-hs) and N-terminal pro-brain natriuretic peptide test (NT-proBNP).
• In 2019, Roche Diagnostics launched the VITROS high-sensitivity Troponin I assay.
As per DelveInsight, the ongoing clinical & commercial development activities and research in the domain will contribute immensely to the Cardiac Biomarkers Testing Devices Market growth in the coming years.
Key Companies in the Cardiac Biomarkers Testing Devices Market
The leading giants in the Cardiac Biomarkers Testing Devices market include Beckman Coulter, Inc, Siemens Healthcare GmbH, Abbott, bioMérieux SA, F. Hoffmann-La Roche Ltd, Thermo Fischer Scientific Inc, Bio-Rad Laboratories Inc, Eurolyser Diagnostica GmbH, Diagnostic Automation / Cortez Diagnostics, Inc, Randox Laboratories Ltd, Tosoh Corporation, DIALAB GmbH, CardioGenics Holdings Inc, Lepu Medical Technology (Beijing) Co. Ltd., Biosynex and others.
As per DelveInsight, due to the high growth rate and positive return, several new players are expected to enter the Cardiac Biomarkers Testing Devices market in the coming years. The entry of new players and the launch of emerging products will immensely drive market growth.
Learn How New Players' Entries Will Transform the Market Dynamics in the Coming Years @
https://www.delveinsight.com/sample-request/cardiac-biomarkers-testing-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Scope of the Cardiac Biomarkers Testing Devices Market Report:
• Study Period - 2020-2028
• Geography Covered - Global (North America, Europe, Asia-Pacific, and the Rest of the World)
• Cardiac Biomarkers Testing Devices Market by Product Type - Instruments And Reagents & Kits
• Cardiac Biomarkers Testing Devices Market by Biomarker Type - Troponin, Creatine Kinase-MB, Natriuretic Peptide, Myoglobin, and Others
• Cardiac Biomarkers Testing Devices Market by Application - Acute Coronary Syndrome, Congestive Heart Failure, Myocardial Infarction, and Others
• Cardiac Biomarkers Testing Devices Market by End User - Hospitals, Pathology Labs, And Others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
DelveInsights' Remark: The "Cardiac Biomarkers Testing Devices Market" is anticipated to grow at a significant CAGR of 7.77% till 2028. North America is expected to dominate the Global Cardiac Biomarkers Testing Devices Market.
Learn More About the Ongoing Clinical, Commercial, And Regulatory Developments in the Market @
https://www.delveinsight.com/sample-request/cardiac-biomarkers-testing-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Table of Content
1. Report Introduction
2. Executive summary
3. Regulatory and Patent Analysis
4. Cardiac Biomarkers Testing Devices Market Key factors analysis
5. Cardiac Biomarkers Testing Devices Porter's Five Forces Analysis
6. COVID-19 Impact Analysis on Cardiac Biomarkers Testing Devices Market
7. Cardiac Biomarkers Testing Devices Market Layout
8. Cardiac Biomarkers Testing Devices Global Company Share Analysis
9. Cardiac Biomarkers Testing Devices Product Profiles and Key Companies
10. Project Approach
11. KOL Views
12. DelveInsight Capabilities
13. Disclaimer
14. About DelveInsight
Download the Sample PDF to Get Detailed Insights About the Report's Offerings @
https://www.delveinsight.com/sample-request/cardiac-biomarkers-testing-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
-------------------------------------------- xx --------------------------------------------
Other Trending Healthcare Reports by DelveInsight
Anti-hypertension Market
https://www.delveinsight.com/report-store/anti-hypertension-market
Lower-Limb Spasticity Market
https://www.delveinsight.com/report-store/lower-limb-spasticity-market
Glioblastoma Market
https://www.delveinsight.com/report-store/glioblastoma-market
Cancer Cachexia (CC) Market
https://www.delveinsight.com/report-store/cancer-cachexia-cc-market-insights
Hepatitis C Market
https://www.delveinsight.com/report-store/hepatitis-c-market
Open-Angle Glaucoma Market
https://www.delveinsight.com/report-store/open-angle-glaucoma-market
Gastroesophageal Reflux Disease (GERD) Market
https://www.delveinsight.com/report-store/gastroesophageal-reflux-disease-gerd-market
Duchenne Muscular Dystrophy Market
https://www.delveinsight.com/report-store/duchenne-muscular-dystrophy-market
Helicobacter Pylori Infections Market
https://www.delveinsight.com/report-store/helicobacter-pylori-infections-market
Cerebral Infarction Market
https://www.delveinsight.com/report-store/cerebral-infarction-market
Gastroesophageal Reflux Disease (GERD) Market
https://www.delveinsight.com/report-store/gastroesophageal-reflux-disease-gerd-market
Papilloma Market
https://www.delveinsight.com/report-store/papilloma-market
Peripheral Neuritis Market
https://www.delveinsight.com/report-store/peripheral-neuritis-market
Renal Insufficiency Market
https://www.delveinsight.com/report-store/renal-insufficiency-market
Dysthymia Market
https://www.delveinsight.com/report-store/dysthymia-market
Persistent Depressive Disorder Market
https://www.delveinsight.com/report-store/persistent-depressive-disorder-market
Relapsing Multiple Sclerosis (RMS) Market
https://www.delveinsight.com/report-store/relapsing-multiple-sclerosis-rms-market
Asthma Market
https://www.delveinsight.com/report-store/asthma-market
Helicobacter Pylori Infections Market
https://www.delveinsight.com/report-store/helicobacter-pylori-infections-market
Corneal Dystrophy Market
https://www.delveinsight.com/report-store/corneal-dystrophy-market
Peripheral Vascular Devices Global Market
https://www.delveinsight.com/report-store/peripheral-vascular-devices-market
Physiotherapy Equipment Market Concussions Market
https://www.delveinsight.com/report-store/concussions-market
Herpes Simplex Market
https://www.delveinsight.com/report-store/herpes-simplex-market
Hairy Cell Leukemia (HCL) Market
https://www.delveinsight.com/report-store/hairy-cell-leukemia-hcl-market
Contact Us
Shruti Thakur
Manager (Marketing & Branding)
info@delveinsight.com
+1(919)321-6187
www.delveinsight.com
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Cardiac Biomarkers Testing Devices Market to Exhibit Growth at a Considerable CAGR of 7.77% by 2028, Estimates DelveInsight | Beckman Coulter, Siemens, Abbott, bioMérieux, Roche, Thermo Fischer Scientific Inc, Bio-Rad, Eurolyser, DIALAB GmbH here
News-ID: 3144387 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Cardiac
Cardiac Resynchronization Therapy: Driving Innovation and Transforming Global Ca …
London, UK - August 2025 | Strategic Revenue Insights Inc. The global cardiac resynchronization therapy (CRT) market is emerging as one of the most crucial sectors in cardiovascular healthcare, offering life-saving solutions for patients with heart failure and conduction abnormalities. CRT devices, including pacemakers and defibrillators, are designed to restore synchronized heart contractions, significantly improving patient survival rates and quality of life. With rising cardiovascular disease prevalence worldwide, CRT has…
Mobile Cardiac Telemetry Systems Market Redefining Remote Cardiac Monitoring
"In recent years, the global Mobile Cardiac Telemetry Systems Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Mobile Cardiac Telemetry Systems Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot…
Ambulatory Cardiac Monitoring Devices Market: Revolutionizing Cardiac Care
In the rapidly evolving landscape of healthcare, the Ambulatory Cardiac Monitoring Devices Market stands out as a beacon of innovation and progress. These devices, including ECG devices, Holter monitors, event monitors, implantable loop recorders, and mobile cardiac telemetry, have become indispensable tools for healthcare professionals in managing and diagnosing cardiac conditions. As heart-related issues continue to afflict millions globally, the demand for advanced cardiac monitoring solutions is on the rise.
Request…
Cardiac Monitoring & Cardiac Rhythm Management Devices Market - Precision Monito …
Newark, New Castle, USA: The "Cardiac Monitoring & Cardiac Rhythm Management Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cardiac Monitoring & Cardiac Rhythm Management Devices…
Cardiac Monitoring & Cardiac Rhythm Management Device Market
According to a new market research report published by Global Market Estimates, the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is expected to grow at a CAGR of 3.88% during the forecast period. The increasing occurrence of dyslipidemia, hypertension, and rising demand for cardiac monitoring & cardiac rhythm management devices to save patients at a huge risk of cardiac arrest.
Browse 145 Market Data Tables and 119 Figures spread…
Global Cardiac Monitoring & Cardiac Rhythm Management Market Insights, Forecast
Cardiac monitoring (CM) devices help in continuous examination of a patient’s cardiac activity. Cardiac rhythm management (CRM) devices maintain normal cardiac rhythm in patients suffering from rate and rhythm disorders of the heart. These devices play a crucial role in the treatment of serious cardiac disorders, including heart failure, atrial fibrillation, atrial flutter, indications of recent heart attack, coronary ischemia, lack of oxygen supply to cardiac muscles, effects of drugs,…
